Tumor-associated macrophages (TAMs) are predominantly M2 phenotype in solid cancers including hepatocellular carcinoma (HCC). Though differentiation of M2 macrophages has been recently linked to fatty acid oxidation (FAO), whether FAO plays a role in functional maintenance of M2 macrophages is still unclear. Here, we used an in vitro model to mimic TAM-HCC interaction in tumor microenvironment. We found that M2 monocyte-derived macrophages (MDMs) enhanced the proliferation, migration, and invasion of HCC cells through an FAO-dependent way. Further investigations identified that IL-1β mediated the pro-migratory effect of M2 MDM. Using etomoxir and siRNA to inhibit FAO and palmitate to enhance FAO, we showed that FAO was responsible for the up-regulated secretion of IL-1β and, thus, the pro-migratory effect in M2 MDMs. In addition, we proved that IL-1β induction was reactive oxygen species and NLRP3-dependent. Our study demonstrates that FAO plays a key role in functional human M2 macrophages by enhancing IL-1β secretion to promote HCC cell migration. These findings provide evidence for different dependency of energy sources in macrophages with distinct phenotypes and functions, and suggest a novel strategy to treat HCC by reprogramming cell metabolism or modulating tumor microenvironment.
Introduction
Tumor-associated macrophages (TAMs) have been proven to enhance tumor progression in various ways including promoting angiogenesis and epithelial-to-mesenchymal transition (EMT) (Noy and Pollard, 2014) . These TAMs harboring tumor-promoting capacity are primarily alternatively-activated M2 phenotype, which-in contrast to M1 phenotype-was previously thought to be anti-inflammatory (Mantovani et al., 2002) . However, recent investigations revealed a pro-inflammatory role of M2 macrophages in certain conditions such as arthritis and pancreatic cancer Vogelpoel et al., 2014) . In reality, macrophages are multi-functional and highly heterogeneous; their phenotypes change rapidly in response to distinct local tissue microenvironments (Gordon et al., 2014) .
The shift of phenotypes in macrophages provokes significant changes of cellular metabolism. Macrophages with M1 phenotype dominantly use glycolysis (like "Warburg effect") while M2 macrophages seem to prefer oxidative phosphorylation, particularly through enhanced fatty acid oxidation (FAO) (Kelly and O'Neill, 2015) . It has been reported that FAO is essential for alternative activation of mouse macrophages (Huang et al., 2014; Vats et al., 2006) . In contrast, FAO is dispensable for human macrophage M2 polarization (Namgaladze and Brune, 2014) . However, whether FAO is required for the functional maintenance of M2 phenotype in macrophages is currently unknown.
TAMs play key roles in various types of solid tumor including hepatocellular carcinoma (HCC) (Shirabe et al., 2012) , however, the mechanisms are still not fully understood. We previously identified a pro-inflammatory role of M2 macrophage in HCC with up-regulated interleukin (IL)-1β secretion, leading to enhanced EMT via hypoxiainducible factor (HIF)-1α in HCC and pancreatic cancer cells Zhang et al., 2018) . In conjunction, FAO promotes NLRP3 inflammasome activation consequently leading to increased IL-1β secretion in both mouse and human macrophages (Moon et al., 2016) . We, thus, asked whether FAO is involved in this event and whether FAO inhibition can reduce TAM-mediated tumor progression.
Materials and methods

Cell culture and reagents
HCC cell lines HepG2 and Hep3 B were derived from American Type Culture Collection (ATCC, Manassas, VA, USA) and were cultured in high glucose (4.5 g/L) Dulbecco's Modified Eagle Medium (DMEM; Thermo Fisher Scientific, Waltham, MA, USA). Huh-7 cells were purchased from Japanese Collection of Research Bioresources (JCRB) Cell Bank (Saito-Asagi, Ibaraki Osaka, Japan) and were cultured in low glucose (1.0 g/L) DMEM (Thermo Fisher Scientific). Human elutriated monocytes were derived from Blood Bank of National Institutes of Health (NIH) donated by healthy people. For macrophage differentiation, monocytes were cultured in RPMI-1640 (Thermo Fisher Scientific) overnight and then cultured in Iscove's Modified Dulbecco's Medium (IMDM; Thermo Fisher Scientific) with 30 ng/ml recombinant human macrophage colony-stimulating factor (M-CSF; Peprotech, Rocky Hill, NJ, USA) for seven days. A half volume of medium was changed and fresh M-CSF was supplemented on the third day of differentiation. All culture medium was supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific) and 1% penicillin/streptomycin (Thermo Fisher Scientific). For induction of M2 phenotype macrophages, cells were treated with 20 ng/ml human recombinant interleukin (IL)-4 (Peprotech) for 24 h.
Etomoxir, bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES), 2-cyano-3-(1-phenyl-1H-indol-3-yl)-2-propenoic acid (UK5099), 2-deoxy-D-glucose (2-DG), N-acetyl cysteine (NAC), 25-hydroxycholesterol (25-HC), glybenclamide, mitoTEMPO, and sodium palmitate were all purchased from Sigma-Aldrich (St. Loius, MO, USA). Bovine serum albumin (BSA)-conjugated palmitate was prepared using BSA and sodium palmitate according to the protocol (Seahorse Bioscience; Agilent Technologies, Santa Clara, CA, USA).
Co-culture and migration/invasion assays
Co-culture of macrophages and HCC cells were performed using Transwell chambers with 8-μm pores on the membrane (Corning, Corning, NY, USA) in a 24-well plate. Macrophages and HCC cells were cultured in the lower and upper compartments of the Transwell chamber, respectively, for 48 h. Macrophages were seeded at a density of 200,000 cells in 0.5 ml medium, and HCC cells were seeded at a density of 225,000 cells in 0.3 ml medium. For invasion assays, 30 μl Matrigel Matrix (1:5 dilution; Corning) was coated for 5 h in the upper compartments. The non-invasive HCC cells in the upper chambers were removed by cotton swabs, and were stained with 0.5% crystal violet solution for 10 min. Migratory or invasive cells were counted under an optical microscope (Nikon, Tokyo, Japan), and results of five high power fields were averaged.
Cell proliferation assays
In brief, 500,000 M2 MDMs were cultured in a 12 well plate with or without etomoxir (100 μM) for 48 h. Supernatants were collected, and floating cells and cell debris were removed by centrifugation (500g, 10 min) at 4°C. Then, 8000 HCC cells were seeded in a 96-well plate and were cultured in normal or conditioned medium (1:1 diluted with fresh complete medium) for 48 h. Cell proliferation was then detected using Cell Counting Kit-8 (Dojindo Molecular Techonlogies, Rockville, MD, USA) according to the manufacture's instructions.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using PureLink RNA Mini Kit (Invitrogen), and was reverse-transcribed to complementary DNA (cDNA) using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen). Totally 200 ng cDNA was used for qRT-PCR using Power SYBR Green PCR Master Mix (Applied Biosystems, Thermo Fisher Scientific) and specific primers. The following primers were used in this study: IL1 B (forward: 5′-TCCAGGGACAGGATATGGAG-3′, reverse: 5′-TCTTTCAACACGCAGGACAG-3′), IL6 (forward: 5′-ATGAACTC CTT CTCCACAAGC-3′, reverse: 5′-GTTTTCTGCCAGTGCCTCTTTG-3′), IL10 (forward: 5′-AGAACCTGAAGACCCTCAGGC-3′, reverse: 5′-CCACGGCC TTGCTCTTGTT-3′), TNFA (forward: 5′-AGGCGCTCCCCAAGAAGAC AGG-3′, reverse: 5′-CAGCAGGCAGAAGAGCGTGGTG-3′), VEGF (forward: 5′-GCCTTGCCTTGCTGCTCTAC-3′, reverse: 5′-TGATTCTGCCCT CCTCCTTCTG-3′), TGFB (forward: 5′-CCCAGCATCTGCAAAGCTC-3′, reverse: 5′-GTCAATGTACAGCTGCCGCA-3′), GAPDH (forward: 5′-AGG GCTGCTTTTAACTCGGT-3′, reverse: 5′-CCCCACTTGATTTTGGAG GGA-3′), mouse Il1b (forward: 5′-GCAACTGTTCCTGAACTCAACT-3′, reverse: 5′-ATCTTTTGGGGTCCGTCAACT-3′), mouse Gapdh (forward: 5′-CAAAATGGTGAAGGTCGGTGTG-3′, reverse: 5′-TGATGTTAGTGG GGTCTCGCTC-3′).
Enzyme-linked immunosorbent assay (ELISA)
For detection of IL-1β in the supernatants, 5 mM adenosine triphosphate (ATP; Sigma-Aldrich) was added 1 h before supernatant collection. IL-1β concentration was then determined using human IL-1β/IL-1F2 Quantikine ELISA Kit (R&D systems, Minneapolis, MN, USA) according to the manufacture's instructions.
Metabolic analyses
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were assessed using Seahorse XFe96 Analyzer (Agilent Technologies). Totally 20,000 macrophages were seeded in each well for 9-12 wells. OCR and ECAR were detected using Seahorse XF Cell Mito Stress Test Kit (Agilent Technologies) according to the manufacture's instructions. FAO-related OCR was performed and calculated using Seahorse XF Mito Fuel Flex Test Kit (Agilent Technologies). The results were normalized to cell number using cell protein concentration.
Small interfering RNA (siRNA) and plasmids transfection
Specific siRNA targeting IL1B, CPT1A, and NLRP3 and negative control (nc)-siRNA were purchased from Thermo Fisher Scientific. Transfection of macrophages was performed using P3 Primary Cell 4D-Nucleofector X Kit and 4D-Nucleofector Unit (Lonza; Walkersville, MD, USA) according to the manufacture's instructions. In all experiments, siRNA was used at 100 nM, and plasmids were used at 3 μg per transfection.
Detection of reactive oxygen species (ROS)
Macrophages were treated as indicated and stained with 4 μM MitoSOX Red Mitochondrial Superoxide Indicator (Thermo Fisher Scientific) for 10 min at 37°C. After washing twice with Hank's Balanced Salt Solution (HBSS)/Ca/Mg, fluorescence was detected using an inverted fluorescence microscope (Nikon).
Lactate detection
Macrophages were cultured in 6-well plate and treated with IL-4 for 24 h, followed by etomoxir treatment for another 36 h. Supernatants were collected, and lactate concentration was determined using a Lactate Colorimetric Assay Kit (BioVision, Milpitas, CA, USA). Samples were tested in duplicates, and totally three donors were included.
Lipid staining
Cellular lipid droplets were stained and quantified using Oil Red O Staining Kit (BioVision) according to the manufacture's instructions.
Xenograft mouse model
The animal experiment was approved by the NCI Animal Care and Use Committee. Nude mice were randomized into two groups, and 1 × 10 6 Huh-7 cells were subcutaneously inoculated. After 10 days, etomoxir (20 mg/kg) was intraperitoneally injected every other day for a total of five times. An equal amount of phosphate buffer saline was injected as a negative control. Xenografts were harvested and homogenized for RNA extraction. The expression of mouse Il1b was detected using qRT-PCR.
Statistical analysis
Data were presented as the means ± standard deviation (SD) or means ± standard error of the mean (SEM), as indicated. Statistical analyses were performed using Prism 6 (GraphPad Software, San Diego, CA, USA). For lactate analysis, paired Student's t test was used. Other continuous variables were analyzed by unpaired Student's t test for comparison between two groups. For all statistical analyses, a P value less than 0.05 was considered statistically significant.
Results
FAO is required for macrophages to exert pro-tumoral effects in HCC cells
To confirm the roles of FAO in terms of TAMs-induced tumor progression, we first used an indirect co-culture method by using the conditioned media of M2-polarized human monocyte-derived macrophages (M2 MDMs) to culture HCC cells. In agreement with previous reports Yeung et al., 2015) , M2 MDM-conditioned medium significantly enhanced the proliferation of HCC cells (Fig. 1A) . Similarly, M2 MDMs also facilitated migration and invasion of HCC cells (Fig. 1B-D) . Of note, these pro-tumoral effects of M2 MDMs could be largely blocked by etomoxir ( Fig. 1A-D) , an FAO inhibitor (Fig. 1E) . However, M0 MDMs had no effects in promoting cell proliferation and a much weaker potential of facilitating cell migration in regard to HCC cells, and these M0 MDM-induced effects had no responses to etomoxir treatment (data not shown).
Given that M2 polarization is associated with increased mitochondrial respiration (Huang et al., 2014) , we asked whether the pro-tumor effects of M2 MDMs in our settings were FAO-specific. The main sources of oxidative respiration for cells are glucose, glutamine, and fatty acid. We thus used BPTES and UK5099 to inhibit glutamine and glucose oxidation, respectively. Neither BPTES nor UK5099 was able show an anti-migratory effect in all three HCC cell lines ( Fig. 2A and B) . Furthermore, we used 25-HC to inhibit fatty acid synthesis, which limited subsequent FAO in M2 MDMs by restraining fatty acid supply (Fig. 2C) . As expected, the M2 MDM-induced HCC migration was impaired with pretreatment of 25-HC ( Fig. 2D and E) . Inversely, when palmitate was added in the presence of 25-HC to support FAO, the M2 MDM-induced HCC migration was restored to a great extent (Fig. 2F) . In support, IL-4 induced M2 polarization in the absence or presence of 25-HC decreased lipid droplets in MDMs while etomoxir partially restored them ( Fig. 2G and H). These results suggested that fatty acid metabolism, particularly FAO, was required for macrophage-induced HCC migration.
FAO inhibition reduces IL-1β expression and secretion
To explore the mechanism by which FAO mediates macrophageenhanced migration in HCC cells, we tested the expression of several pro-invasive/migratory cytokines including tumor necrosis factor (TNF)-α, IL-1β, IL-6, IL-10, vascular endothelial growth factor (VEGF), transform growth factor (TGF)-β, and matrix metalloproteinase (MMP) 9 in M2 MDMs co-cultured with HCC cells to seek the ones that could be inhibited by etomoxir. Among these cytokines, only IL-1β and IL-6 were Oxygen consumption rate and extracellular acidification rate were detected by Seahorse assays. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) significantly down-regulated in the presence of etomoxir (Fig. 3A) . IL-1β is a potent HIF-1α inducer even at a very low concentration in normoxia (Frede et al., 2005; Zhang et al., 2018) , and can induce EMT in many types of cancer including HCC (Li et al., 2012; Liu, 2008; Zhang et al., 2018) . A previous study also showed that etomoxir suppressed Il1b expression (Xu et al., 2015) . Intriguingly, in M0 MDMs, etomoxir slightly increased rather than decreased IL1 B transcription (data not shown). We thus hypothesized that IL-1β might be critical for etomoxir to affect M2 MDM-induced tumor migration. However, we only detected significant IL-1β secretion in MDMs after IL-4 treatment when co-cultured with HCC cells and non-significant IL-1β in HCC cell absence (data not shown). Although the exact reason is unknown, this result may be due to some HCC cell-derived stimulators such as IgG (Vogelpoel et al., 2014; Yi et al., 2015) .
When we used IL1 B siRNA to interfere IL-1β expression in M2 MDMs co-cultured with HCC cells, the pro-migratory effect of MDMs was inhibited (Fig. 3B) , indicating an IL-1β-mediated pro-migratory effect of macrophages. Intriguingly, the secretion of IL-1β is comparable in TAMs of both M1 and M2 phenotypes within tumor microenvironments . However, the mechanisms underlying IL-1β secretion in M1 and M2 TAMs are supposed to be different. It is well known that glycolysis contributes to IL-1β expression and secretion in M1 macrophages; yet, the mechanistic and metabolic involvements of IL-1β secretion in M2 macrophages are unclear and probably cannot be explained by glycolysis due to their FAO preference. Nevertheless, we found that 2-DG-mediated glycolysis inhibition in M2 MDMs significantly down-regulated IL1 B transcription and MDM-induced HCC migration ( Fig. 3C and D) , demonstrating that glycolysis was still critical in M2 macrophages. In addition, we found the mRNA and protein levels of IL1 B were decreased by etomoxir in M2 MDMs co-cultured with HCC cells (Fig. 4A and B) . The etomoxir-induced inhibition of Il1b transcription was further confirmed in a xenograft mouse model (Fig. 4C) . In parallel, when palmitate was added to enhance FAO in M2 MDMs, IL-1β expression and secretion was further enhanced (Fig. 4D  and E) . Furthermore, we found that palmitate-enhanced IL-1β expression could be partially blocked by knockdown of CPT1A using siRNA ( Fig. 4F and G) , which encodes a protein critical for transporting fatty acids into mitochondria for FAO-mediated degradation. As expected, CPT1A knockdown reduced FAO of M2 MDMs (Fig. 4H) .
We then investigated whether FAO also affects the maturation of IL-1β, given that FAO can promote NLRP3 activation (Moon et al., 2016) . We analyzed the secretion of IL-1β in MDMs co-cultured with HCC cells in response to the specific NLRP3 inflammasome activator ATP. Enhanced FAO by palmitate promoted IL-1β secretion, while NLRP3 siRNA transfection significantly impaired this effect of palmitate in MDMs (Fig. 5A) . Consistently, macrophages treated with Cellular lipid was stained and quantified using Oil Red O. Bar, 100 μm. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) glybenclamide, an inhibitor of NLRP3 inflammasome (Lamkanfi et al., 2009) , showed a steady and remarkable decrease of IL-1β secretion regardless of palmitate addition (Fig. 5B) . A reduced pro-migratory effect of M2 MDMs was also observed in the presence of glybenclamide (Fig. 5C ). According to these findings, we inferred that FAO regulated MDM-induced HCC migration by promoting IL-1β expression and secretion.
ROS is critical in FAO-associated IL-1β expression
Although we showed that 2-DG inhibited HCC cell-induced IL1 B transcription in MDMs, co-culture with HCC cells did not significantly enhance glycolysis of M2 MDMs in our settings (Fig. 6A) . Similarly, etomoxir failed to induce glycolysis as suggested by comparable levels of ECAR and released lactate in M2 MDMs with or without etomoxir treatment (Figs. E B) . These findings suggested that glycolysis probably served as a basal and constitutional energy source and that an alternative way of IL-1β induction by FAO might exist.
We thus explored the mechanism by which IL-1β was induced by FAO. Since FAO produces more ROS than glycolysis (Rosca et al., 2012) , and ROS can induce IL-1β expression in macrophages (Mills et al., 2016) , we tested whether ROS mediated FAO-induced IL-1β in M2 MDMs. A decreased oxygen consumption rate of M2 MDMs in case of tumor cell co-culture suggested the metabolic repurposing of mitochondrial from ATP generation to ROS generation (Fig. 6A) , similar to the previous report (Mills et al., 2016) . Similar to previous studies (Snodgrass et al., 2015) , depletion of ROS by NAC decreased the mRNA level of IL1 B in M2 MDMs (Fig. 6C) . NAC also weakened the pro-migratory effect of MDMs in both HepG2 and Hep3 B cells (Fig. 6D and E) .
Using mitoTEMPO, a mitochondria-targeted antioxidant, we observed a similar pattern of alterations with NAC (Fig. 6F) . Because FAO is dependent on oxidative respiration in mitochondria, we further confirmed that inhibition of FAO by etomoxir led to decreased ROS (Fig. 6G) . Altogether, these results indicated that ROS mediated FAO-associated IL-1β expression in M2 macrophages.
Discussion
Different microenvironments influence many immune cells, including macrophages and T lymphocytes, to express distinct and even opposite functions; recent studies have linked this phenotypic shift in macrophages to metabolic change (Kelly and O'Neill, 2015) . It is established that macrophages are dependent on glycolysis for classic activation; however, there is no consensus of metabolic dependency in alternatively activated macrophages. A few investigations reported that FAO plays key roles in macrophage alternative activation, but the conclusions were conflicting between human and murine results. Finkel's group and Wolfgang's group independently argued for the misleading conclusion that FAO plays a role in M2 polarization using bone marrow-derived macrophages by providing limited but convincing data acquired from a CPT2A conditional knockout mouse model (GonzalezHurtado et al., 2017; Nomura et al., 2016) . While it seems convincing if two separate groups come to the same conclusion, this discrepancy may be explained by two reasons. On one hand, there may be an off-target effect of etomoxir or a FAO-irrelevant role of CPT1A because etomoxir did impair M2 polarization of macrophages in various ways (Huang et al., 2014; Vats et al., 2006) . On the other hand, a subset of bone marrow-derived macrophages may have low expression of lysozyme M- encoding locus (Lyz2) (Vannella et al., 2014) , which was used to introduce conditional CPT2A knockout in macrophages in the two abovementioned studies. If the effect of FAO on M2 polarization of macrophage is highly flexible and redundant, it is likely that only extensive or even complete inhibition of FAO can compromise alternative activation of macrophages. Therefore, further data are needed to figure out whether FAO is necessary for alternative activation in human macrophages. Furthermore, the role of FAO in maintenance of the function of M2 macrophages is also unclear. Here, we reported that in M2 MDMs, FAO enhanced IL-1β secretion by a ROS and NLRP3-dependent manner and further facilitated MDM-induced malignant characteristics, especially migration of HCC cells. To show the effect of FAO we used different approaches including etomoxir, 25-HC, and siCPT1A to limit the FAO. However, these approaches still have some limitations. Etomoxir and siCTP1A may be argued by their FAO-irrelevant effects of CPT1A. 25-HC may affect tumor cell migration through other mechanisms. In fact, 25-HC slightly promoted tumor cell migration in the absence of macrophages as shown in our study, similar to the results observed in lung cancer (Chen et al., 2017) . However, in the presence of macrophages, 25-HC reduced IL-1β production (Chen et al., 2017; Reboldi et al., 2014) and largely eliminated the IL-1β-enhanced migration of tumor cells. Taken these fingdings together, we believe FAO plays a role in macrophage-mediated enhancement of tumor cell migration.
In order to further investigate this pathway, we needed to delve into the novel field of immunometabolism since changes of macrophages were found closely related to cellular metabolism. For example, mitochondria within macrophages can be repurposed between ATP generation and ROS production according to an M2 or M1 inductor (Mills et al., 2016) . The state of mitochondria-predominantly ATP or ROS production-also influences phenotypic shift of macrophages (Van den Bossche et al., 2016) . The slightly decreased OCR and potentially increased ROS in the presence of tumor cells in our study also suggested . FAO-related oxygen consumption rate was determined by Seahorse. *, P < 0.05; **, P < 0.01; ***, P < 0.001. mitochondrial repurposing from ATP production to ROS generation. Despite these findings, the causal relationship between shifting of metabolism and gene expression is still unclear. We know that mitochondria-derived ROS seems to play key roles in macrophages in both M1 and M2 scenarios. On the other hand, ATP generated by oxidative phosphorylation or by glycolysis is not likely to be a defining factor of phenotype and function of macrophages. The predominance of glycolysis or oxidative phosphorylation in macrophages may be explained by the accompanied metabolites-related gene expression or cellular material synthesis. In our study, we used IL-4-induced M2 MDMs to mimic the M2 TAMs frequently found in tumor microenvironment. We showed that, similar to M1 macrophages, M2 MDMs also secreted IL-1β in the presence of cancer cells through FAO-associated ROS production, which could provoke IL1 B transcription via up-regulation of Hif-1α (Mills et al., 2016) . Proving that some M2 macrophage functions, such as HCC cell-induced pro-inflammatory and pro-migratory effects, relied on FAO, we found a new clue towards establishing the relation between macrophage FAO metabolism and function.
As versatile cells, macrophages present distinct functions and phenotypes depending on the local microenvironments in vivo (Ruffell et al., 2012) . Our data confirmed that the functional change of macrophages could be achieved merely by modulating energy sources such as palmitate. Palmitate was found to promote inflammation in human macrophages (Snodgrass et al., 2015) . However, we noticed that the effects of palmitate and etomoxir in human MDMs were highly casedependent, though the exact reasons are under investigation. Currently, many studies have shown that HCC has altered fatty acid metabolism. For instance, HCC cells up-regulate de novo lipogenesis and downregulate FAO . Although this conclusion was still under debate because other investigators observed elevated FAO in HCC Nath et al., 2015) , our studies support this hypothesis by suggesting that the reprogrammed fatty acid metabolism of cancer cells may affect the function of TAMs by altering the amount of fatty acids in tumor microenvironment. Therefore, modulating energy . Mitochondrial ROS was determined using MitoSOX. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant. sources in tumor microenvironment or targeting fatty acid metabolism in TAMs and cancer cells can be novel strategies in HCC treatment. In fact, some pioneer work has suggested the anti-tumoral efficacy of etomoxir in HCC, lung cancer, and breast cancer (Camarda et al., 2016; Li et al., 2013; Schlaepfer et al., 2014; Wang et al., 2016) . As far as we know, our study revealed for the first time that the M2 macrophage is another target of anti-FAO therapy in solid cancers.
Our final investigation looked towards the pro-inflammatory identities of macrophages as a result of modulation of cellular metabolism. An integral part of pro-inflammatory identities is the pro-inflammatory cytokine IL-1β. This cytokine was traditionally believed to be mainly secreted by M1 macrophages. We, together with other groups, revealed that M2 macrophages show IL-1β secretion and pro-inflammatory effects with minimal to no change of M2 markers in several diseases such as cancer and arthritis (Vogelpoel et al., 2014) . The mechanisms of proinflammatory effects in M2 macrophages are largely unknown. Currently, limited evidence argues that though M1 and M2 macrophages both have pro-inflammatory identities and suggests that the mechanisms differ between macrophage subtypes. As an example, glycolysis is involved in both M1 and M2 macrophage-related inflammation, but functions through different pathways. Glycolysis is predominant in and enhances pro-inflammatory effects of M1 macrophages (Galvan-Pena and O'Neill, 2014) ; whereas, similar with previous reports (Chiba et al., 2017) , we demonstrate that glycolysis more likely plays a basal role in M2 MDMs. We also noticed that palmitate failed to enhance IL1 B transcription in M1 MDMs induced by lipopolysaccharide and interferon-γ (data not shown). In addition, etomoxir was reported to suppress the expression of IL-10, an anti-inflammatory cytokine, in M2 MDMs (Chiba et al., 2017) . Thus, FAO seems to be more important in the pro-inflammatory effects of M2 macrophages, most likely in taking advantage of powerful mitochondrial respiration and avoiding frequent conversion between different energy supply modes in a rapidly changing microenvironment.
The interaction between tumor cells and macrophages seems important for the pro-inflammatory role of M2 macrophages since the presence of tumor cells significantly increased IL-1β production in M2 macrophages. While the exact mechanisms of this phenomenon are largely unknown, our recent studies revealed that tumor cell-derived IgG and O-glycoproteins promoted IL-1β production through FcγRI/IIISyk and TLR4-TRIF signaling pathways, respectively (data not shown). However, further investigations are needed.
In conclusion, we demonstrate that FAO plays a critical role in M2 macrophage-enhanced tumor migration in a cancer cell co-cultural setting mimicking tumor microenvironment. M2 macrophage-secreted IL-1β can be regulated by modulation of FAO through an ROS and NLRP3-dependent manner (Fig. 7) . We demonstrate that certain functions of M2 macrophages, such as IL-1β secretion in tumor microenvironment, rely on FAO. Our study provides a novel perspective of immunometabolism in regulation of tumor migration.
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